Stereospecificity of short Rev-derived peptide interactions with RRE IIB RNA

RNA

Volumn 9, Issue 8, 2003, Pages 937-948

  Litovchick, Alexander ^a   Rando, Robert R ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

helix; hairpin; D and L Rev peptides; Fluorescence anisotropy; HIV 1 RNA; RRE IIB; Stereospecificity

Indexed keywords

REGULATOR PROTEIN; REV PROTEIN; RNA;

ARTICLE; BINDING AFFINITY; BINDING SITE; CIRCULAR DICHROISM; COMPLEX FORMATION; ENANTIOMER; FLUORESCENCE SPECTROSCOPY; HUMAN IMMUNODEFICIENCY VIRUS 1; MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN RNA BINDING; REV RESPONSIVE ELEMENT; RNA ANALYSIS; RNA FOOTPRINTING; RNA STRUCTURE; STEREOSPECIFICITY;

AMINO ACID SEQUENCE; BASE SEQUENCE; BINDING SITES; CIRCULAR DICHROISM; GENE PRODUCTS, REV; HIV-1; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; PEPTIDE FRAGMENTS; PROTEIN BINDING; RNA, MESSENGER; RNA, VIRAL; SPECTROMETRY, FLUORESCENCE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0041305821     PISSN: 13558382     EISSN: None     Source Type: Journal    
DOI: 10.1261/rna.2172103     Document Type: Article

References (24)

1. Bartel, D.P., Zapp, M.L., Green, M.R., and Szostak, J.W. 1991. HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell 67: 529-536.
2. Battiste, J.L., Mao, H., Rao, N.S., Tan, R., Muhandiram, D.R., Kay, L.E., Frankel, A.D., and Williamson, J.R. 1996. α helix-RNA major groove recognition in an HIV-1 Rev peptide-RRE RNA complex. Science 273: 547-1551.
3. Brooks, B.R., Bruccoleri, R.E., Olafson, B.D., States, D.J., Swaminathan, S., and Karplus, M. 1983. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J. Comp. Chem. 4: 187-217.
4. Chen, L. and Frankel, A.D. 1995. A peptide interaction in the major groove of RNA resembles protein interactions in the minor groove of DNA. Proc. Natl. Acad. Sci. 92: 5077-5081.
5. Daly, T.J., Doten, R.C., Rusche, J.R., and Auer, M. 1995. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA. J. Mol. Biol. 253: 243-258.
6. Dauber-Osguthorpe, P., Roberts, V.A., Osguthorpe, D.J., Wolff, J., Genest, M., and Hagler, A.T. 1988. Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase-trimethoprim, a drug-receptor system. Proteins, Struct. Funct. Genet. 4: 31-47.
7. Frankel, A.D. and Young, J.A.T. 1998. HIV-1: Fifteen proteins and an RNA. Annu. Rev. Biochem. 67: 1-25.
8. Garbesi, A., Hamy, F., Maffini, M., Albrecht, G., and Klimkait, T. 1998. TAR-RNA binding by HIV-1 Tat protein is selectively inhibited by its L-enantiomer. Nucleic Acids Res. 26: 2886-2890.
9. Haddad, J., Kotra, L.P., Llano-Sotelo, B., Kim, C., Azucena Jr., E.F., Liu, M., Vakulenko, S.B., Chow, C.S., and Mobashery, S. 2002. Design of novel antibiotics that bind to the ribosomal acyltransfer site. J. Am. Chem. Soc. 124: 3229-3237.
10. Hamasaki, K. and Rando, R.R. 1998. A high-throughput fluorescence screen to monitor the specific binding of antagonists to RNA targets. Anal. Biochem. 261: 183-190.
11. Henderson, B.R. and Percipalle, P. 1997. Interactions between HIV Rev and nuclear import and export factors: The Rev nuclear localisation signal mediates specific binding to human importin-β. J. Mol. Biol. 274: 693-707.
12. Huq, I., Ping, Y-H., Tamilarasu, N., and Rana, T.M. 1999. Controlling human immunodeficiency virus type 1 gene expression by unnatural peptides. Biochemistry 38: 5172-5177.
13. Hutchinson, E.G. and Thornton, J.M. 1994. A revised set of potentials for β-turn formation in proteins. Protein Sci. 3: 2207-2216.
14. Karn, J. 1991. Control of human immunodeficiency virus replication by the tat, rev, nef and protease genes. Curr. Opin. Immunol. 3: 526-536.
15. Kjems, J., Frankel, A.D., and Sharp, P.A. 1991. Specific regulation of mRNA splicing in vitro by a peptide from HIV-1. Rev. Cell 67: 169-178.
16. Kjems, J., Brown, M., Chang, D.D., and Sharp, P.A. 1992. Specific binding of a basic peptide from HIV-1. Rev. EMBO J. 11: 1119-1129.
17. Lacourciere, K.A., Stivers, T.J., and Marino, J.P. 2000. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy. Biochemistry 39: 5630-5641.
18. Pollard, V.W. and Malim, M.H. 1998. The HIV-1 Rev protein. Annu. Rev. Microbiol. 52: 491-532.
19. Tan, R. and Frankel, A.D. 1994. Costabilization of peptide and RNA structure in an HIV Rev peptide-RRE complex. Biochemistry 48: 14579-14585.
20. Tan, R., Chen, L., Buettner, J.A., Hudson, D., and Frankel, A.D. 1993. RNA recognition by an isolated α helix. Cell 73: 1031-1040.
21. Van Ryk, D.I. and Venkatesan, S. 1999. Real-time kinetics of HIV-1 Rev-Rev response element interactions. Definition of minimal binding sites on RNA and protein and stoichiometric analysis. J. Biol. Chem. 274: 17452-17463.
22. Walter, A.E., Turner, D.H., Kim, J., Lyttle, M.H., Muller, P., Mathews, D.H., and Zuker, M. 1994. Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding. Proc. Natl. Acad. Sci. 91: 9218-9222.
23. Wang, Y., Hamasaki, K., and Rando, R.R. 1997. Specificity of aminoglycoside binding to RNA constructs derived from the 16S rRNA decoding region and the HIV-RRE activator region. Biochemistry 36: 768-779.
24. Woody, R.W. 1995. Circular dichroism. Methods Enzymol. 246: 34-71.